Advisory Services Network
CUE icon

Advisory Services Network’s Cue Biopharma CUE Stock Holding History

Advisory Services Network’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$46 – 2700
2026
Q1 		$46 Buy
+7
New +$65 ﹤0.01% 4768
2025
Q4 		– Sell
-7
Closed -$144 – 2344
2025
Q3 		$144 Buy
+7
New +$164 ﹤0.01% 4277
2024
Q1 		– Sell
-7
Closed -$528 – 1918
2023
Q4 		$528 Buy
+7
New +$500 ﹤0.01% 3614
2023
Q2 		– Sell
-7
Closed -$714 – 1919
2023
Q1 		$714 Hold
7
– – ﹤0.01% 3672
2022
Q4 		$570 Buy
+7
New +$640 ﹤0.01% 3719
2020
Q4 		– Sell
-3
Closed -$2K – 3373
2020
Q3 		$2K Buy
+3
New +$1.73K ﹤0.01% 3088

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Advisory Services Network's CUE Position: Q2 2026 in Review

Advisory Services Network sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 7 shares — an estimated $46 sold.

Advisory Services Network first reported a position in CUE in Q3 2020 and held it in 6 quarters. The position peaked at $2K in Q3 2020. 50 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Advisory Services Network reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 7 Cue Biopharma shares in Q2 2026, an estimated $46.
  • Advisory Services Network first reported a position in Cue Biopharma in Q3 2020 and held it in 6 quarters.
  • Advisory Services Network's Cue Biopharma position peaked at $2K in Q3 2020.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.